Effects of Anti–Receptor Activator of Nuclear Factor Kappa B Ligand Antibody and Zoledronic Acid on Periapical Lesion Development in Mice

Antiresorptive drugs are widely used to treat osteoporosis and other systemic bone diseases, although their efficacy for local bone resorption after localized inflammation has not been fully elucidated. We examined the effects of an anti–receptor activator of nuclear factor kappa B ligand (RANKL) an...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of endodontics 2022-05, Vol.48 (5), p.632-640
Hauptverfasser:	Ikeda, Megumi, Karakawa, Akiko, Takizawa, Hideomi, Azetsu, Yuki, Sakai, Nobuhiro, Chatani, Masahiro, Suzuki, Noriyuki, Takami, Masamichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-RANKL antibody osteoclast periapical lesion zoledronic acid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!